Hemolytic-uremic syndrome physical examination: Difference between revisions
Jump to navigation
Jump to search
| Line 41: | Line 41: | ||
| doi = 10.1681/ASN.2004100861 | | doi = 10.1681/ASN.2004100861 | ||
| pmid = 15728781 | | pmid = 15728781 | ||
}}</ref> | }}</ref><ref name=":0">{{Cite journal | ||
| author = [[Olivia Boyer]] & [[Patrick Niaudet]] | | author = [[Olivia Boyer]] & [[Patrick Niaudet]] | ||
| title = Hemolytic uremic syndrome: new developments in pathogenesis and treatment | | title = Hemolytic uremic syndrome: new developments in pathogenesis and treatment | ||
| Line 62: | Line 51: | ||
| doi = 10.4061/2011/908407 | | doi = 10.4061/2011/908407 | ||
| pmid = 21876803 | | pmid = 21876803 | ||
}}</ref> <ref name=":1">{{Cite journal | }}</ref><ref name=":1">{{Cite journal | ||
| author = [[Sylvie Nathanson]], [[Theresa Kwon]], [[Monique Elmaleh]], [[Marina Charbit]], [[Emma Allain Launay]], [[Jerome Harambat]], [[Muriel Brun]], [[Bruno Ranchin]], [[Flavio Bandin]], [[Sylvie Cloarec]], [[Guylhene Bourdat-Michel]], [[Christine Pietrement]], [[Gerard Champion]], [[Tim Ulinski]] & [[Georges Deschenes]] | | author = [[Sylvie Nathanson]], [[Theresa Kwon]], [[Monique Elmaleh]], [[Marina Charbit]], [[Emma Allain Launay]], [[Jerome Harambat]], [[Muriel Brun]], [[Bruno Ranchin]], [[Flavio Bandin]], [[Sylvie Cloarec]], [[Guylhene Bourdat-Michel]], [[Christine Pietrement]], [[Gerard Champion]], [[Tim Ulinski]] & [[Georges Deschenes]] | ||
| title = Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome | | title = Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome | ||
| Line 75: | Line 64: | ||
}}</ref> | }}</ref> | ||
===Vital Signs | *[[Edema]], | ||
*[[Hypertension]] | |||
*[[Fluid overload]] | |||
*Pallor (often severe) | |||
===Appearance of the Patient=== | |||
*Patients with HUS usually appear pale | |||
===Vital Signs === | |||
*fever(in some cases) | *fever(in some cases) | ||
Revision as of 20:33, 6 August 2018
|
Hemolytic-uremic syndrome Microchapters |
|
Differentiating Hemolytic-uremic syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hemolytic-uremic syndrome physical examination On the Web |
|
American Roentgen Ray Society Images of Hemolytic-uremic syndrome physical examination |
|
Risk calculators and risk factors for Hemolytic-uremic syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].
OR
Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].
OR
The presence of [finding(s)] on physical examination is diagnostic of [disease name].
OR
The presence of [finding(s)] on physical examination is highly suggestive of [disease name].
Physical Examination
Physical examination of patients with HUS is usually :[1][2][3][4]
- Pallor (often severe)
Appearance of the Patient
- Patients with HUS usually appear pale
Vital Signs
- fever(in some cases)
- Weak pulse
- High blood pressure with normal pulse pressure
Skin
- Skin examination of patients with HUS] is usually pale.
HEENT
- HEENT examination of patients with HUS is usually normal.
Neck
- Neck examination of patients with HUS is usually normal.
Lungs
- Pulmonary examination of patients with HUS is usually normal.
Heart
- Cardiovascular examination of patients with HUs is usually normal.
Abdomen
- Abdominal distention
- Abdominal tenderness
- Guarding may be present
Back
- Back examination of patients with HUS is usually normal.
Genitourinary
- Genitourinary examination of patients with is usually normal.
Neuromuscular
- Neuromuscular examination of patients with HUS is usually normal.
- Patient is usually oriented to persons, place, and time
- Altered mental status, some patients are in coma
Extremities
- Extremities examination of patients with HUS is usually normal.
References
- ↑ Marina Noris, Jessica Caprioli, Elena Bresin, Chiara Mossali, Gaia Pianetti, Sara Gamba, Erica Daina, Chiara Fenili, Federica Castelletti, Annalisa Sorosina, Rossella Piras, Roberta Donadelli, Ramona Maranta, Irene van der Meer, Edward M. Conway, Peter F. Zipfel, Timothy H. Goodship & Giuseppe Remuzzi (2010). "Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype". Clinical journal of the American Society of Nephrology : CJASN. 5 (10): 1844–1859. doi:10.2215/CJN.02210310. PMID 20595690. Unknown parameter
|month=ignored (help) - ↑ Marina Noris & Giuseppe Remuzzi (2005). "Hemolytic uremic syndrome". Journal of the American Society of Nephrology : JASN. 16 (4): 1035–1050. doi:10.1681/ASN.2004100861. PMID 15728781. Unknown parameter
|month=ignored (help) - ↑ Olivia Boyer & Patrick Niaudet (2011). "Hemolytic uremic syndrome: new developments in pathogenesis and treatment". International journal of nephrology. 2011: 908407. doi:10.4061/2011/908407. PMID 21876803.
- ↑ Sylvie Nathanson, Theresa Kwon, Monique Elmaleh, Marina Charbit, Emma Allain Launay, Jerome Harambat, Muriel Brun, Bruno Ranchin, Flavio Bandin, Sylvie Cloarec, Guylhene Bourdat-Michel, Christine Pietrement, Gerard Champion, Tim Ulinski & Georges Deschenes (2010). "Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome". Clinical journal of the American Society of Nephrology : CJASN. 5 (7): 1218–1228. doi:10.2215/CJN.08921209. PMID 20498239. Unknown parameter
|month=ignored (help)